Product Information
VENLAFAXINE HCL ER 225 MG TAB is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.5160 per EA under NDC 72241007704. Its NADAC has been published 25 times since Jan 7, 2026.
Strength
225 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241007704
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211323On Market Since
1/5/2018
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 225 MG TAB has been published 25 times since Jan 7, 2026, and over the history we have for it it has risen 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5160 per EA |
|---|---|
| All-time high | $0.5293 (Jun 10, 2026) |
| All-time low | $0.4955 (Mar 18, 2026) |
| 52-week high | $0.5293 |
| 52-week low | $0.4955 |
| Median price | $0.5042 |
| Average price | $0.5069 |
| Largest weekly change | +3.8% (May 20, 2026) |
| Weeks tracked | 25 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 225 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 225 MG TAB, manufactured by Modavar Pharmaceuticals LLC, is $0.5160 per EA (NDC 72241007704), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 225 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has risen 2.9%. It has been tracked across 25 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 225 MG TAB?
Since Jan 7, 2026, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has ranged from a low of $0.4955 (Mar 18, 2026) to a high of $0.5293 (Jun 10, 2026), with a median of $0.5042 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 225 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 225 MG TAB, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 225 MG TAB?
VENLAFAXINE HCL ER 225 MG TAB (NDC 72241007704) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification